case_images: PMC4531964_01
case_images: CsA trough levels before, during and after PMC administration (Case 1).
case_images: kjim-12-1-67-12f1.jpg
case_images: PMC4531964_01_kjim-12-1-67-12f1.jpg
case_images: f1-kjim-12-1-67-12
case_images: Upon cessation of PMC treatment, the CsA trough rose gradually, reaching 106.6mg/ml after 4 weeks and 137.4ng/ml after 8 weeks (Fig. 1).
case_images: PMC4531964_02
case_images: CsA trough levels before, during and after PMC administration (Case 2).
case_images: kjim-12-1-67-12f2.jpg
case_images: PMC4531964_02_kjim-12-1-67-12f2.jpg
case_images: f2-kjim-12-1-67-12
case_images: Seven weeks after discontinuation of PMC treatment, the CsA trough rose 73.3ng/ml and, 12 weeks after, it reached 120.0ng/ml (Fig. 2).